S3840Temporary National Codes (Non-Medicare)
Dna analysis for germline mutations of the ret proto-oncogene for
Short description: Dna analysis ret-oncogene
- Effective date
- July 1, 2003
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3840?
S3840 is a HCPCS Level II code for Dna analysis for germline mutations of the ret proto-oncogene for.
What category is HCPCS code S3840 in?
S3840 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3840 become effective?
S3840 has been effective since July 1, 2003, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.